Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma

Pediatr Hematol Oncol. 2001 Jun;18(4):253-8. doi: 10.1080/088800101750238559.

Abstract

The prognosis for patients with malignant brainstem tumors is poor. The authors report on a 6-year-old girl with a biopsy proven pontine glioblastoma, who, after initial chemo-radiotherapy and tumor progression, experienced a prolonged second response to a salvage therapy consisting of cisplatin, etoposide, and ifosfamide. The patient recovered from her life-threatening condition with almost complete resolution of all neurologic deficits paralleled by a dramatic shrinkage of the tumor documented by magnetic resonance imaging.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Brain Stem Neoplasms / diagnosis
  • Brain Stem Neoplasms / drug therapy
  • Brain Stem Neoplasms / radiotherapy
  • Child
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Glioblastoma / diagnosis
  • Glioblastoma / drug therapy*
  • Glioblastoma / radiotherapy
  • Humans
  • Ifosfamide / administration & dosage
  • Magnetic Resonance Imaging
  • Recurrence
  • Remission Induction
  • Salvage Therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Etoposide
  • Cisplatin
  • Ifosfamide